Epstein-Barr Virus Infection Induces Indoleamine 2,3-Dioxygenase Expression in Human Monocyte-Derived Macrophages through p38/Mitogen-Activated Protein Kinase and NF- B Pathways: Impairment in T Cell Functions

Pathogenic role of Epstein–Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma

(2013) Tomokazu Yoshizaki et al.   CANCER LETTERS

Remarkable Role of Indoleamine 2,3-Dioxygenase and Tryptophan Metabolites in Infectious Diseases: Potential Role in Macrophage-Mediated Inflammatory Diseases

(2013) Yuki Murakami et al.   MEDIATORS OF INFLAMMATION

Nasopharyngeal carcinoma incidence and mortality in China in 2009

(2013) Zhi-Jian Xu et al.   Chinese Journal of Cancer

Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases

(2012) G. C. Prendergast et al.   CURRENT MEDICINAL CHEMISTRY

Host Indoleamine 2,3-Dioxygenase: Contribution to Systemic Acquired Tumor Tolerance

(2012) Theodore S. Johnson et al.   IMMUNOLOGICAL INVESTIGATIONS

Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression

(2012) Hyangin Kim et al.   JOURNAL OF CLINICAL INVESTIGATION

Flavivirus infection induces indoleamine 2,3-dioxygenase in human monocyte-derived macrophages via tumor necrosis factor and NF- B

(2012) A. W. S. Yeung et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Involvement of Indoleamine 2,3-Dioxygenase in Impairing Tumor-Infiltrating CD8+T-Cell Functions in Esophageal Squamous Cell Carcinoma

(2011) Ge Zhang et al.   Clinical & Developmental Immunology

The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression

(2011) J. de Souza Sales et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway

(2011) Hyunkeun Song et al.   IMMUNOLOGY LETTERS

Haemophilus ducreyi Lipooligosaccharides Induce Expression of the Immunosuppressive Enzyme Indoleamine 2,3-Dioxygenase via Type I Interferons and Tumor Necrosis Factor Alpha in Human Dendritic Cells

(2011) Wei Li et al.   INFECTION AND IMMUNITY

HIV-1 Tat activates indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures in a p38 mitogen-activated protein kinase-dependent manner

(2011) Xin Fu et al.   Journal of Neuroinflammation

Macrophage involvement in Epstein-Barr virus-related tumors

(2010) MISUZU SHIMAKAGE et al.   Experimental and Therapeutic Medicine

Expression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes

(2009) Peng Liu et al.   BMC CANCER

Increased activity of indoleamine 2,3-dioxygenase in serum from acutely infected dengue patients linked to gamma interferon antiviral function

(2009) A. Becerra et al.   JOURNAL OF GENERAL VIROLOGY

Reduced Cytotoxic Function of Effector CD8+ T Cells Is Responsible for Indoleamine 2,3-Dioxygenase-Dependent Immune Suppression

(2009) H. Liu et al.   JOURNAL OF IMMUNOLOGY

Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape

(2008) Jessica B. Katz et al.   IMMUNOLOGICAL REVIEWS

Tumor-derived Variants of Epstein-Barr Virus Latent Membrane Protein 1 Induce Sustained Erk Activation and c-Fos

(2008) Maria Vaysberg et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Epstein-Barr Virus-Encoded LMP1 Regulates Epithelial Cell Motility and Invasion via the ERK-MAPK Pathway

(2008) C. W. Dawson et al.   JOURNAL OF VIROLOGY

Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host

(2008) T ZELANTE et al.   MICROBES AND INFECTION